Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet

Completed · Phase 3

Conditions studied: Analgesia

In brief

A self-selection and actual use trial to evaluate the extent to which consumers will appropriately select and use the 600 mg immediate release/extended release caplets and comply with dosing instructions.

Key facts

Study ID
NCT01789606
Run by
Pfizer
People needed
1083
Starts
2012-09-24
Expected to finish
2013-06-03
Last updated by the study team
2017-08-28

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.